FDA approves Biogen and Ionis’ Tofersen for rare genetic form of ALS
Medical Marketing and Media,
The FDA’s decision came just over a month after an advisory committee issued a mixed vote on Tofersen.
The FDA’s decision came just over a month after an advisory committee issued a mixed vote on Tofersen.
At the recent 2023 International Conference on Alzheimer's and Parkinson's Diseases in Sweden, thousands of medical and…
Lewczuk P, Ermann N, Andreasson U, Schultheis C, Podhorna J, Spitzer P, Maler JM, Kornhuber J, Blennow K, Zetterberg H.
A growing body of evidence suggests that the plasma concentration of the neurofilament light chain (NfL) might be considered a…